BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22367278)

  • 1. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
    Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
    J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
    Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
    Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation.
    Wu KC; Liu J; Klaassen CD
    Toxicol Appl Pharmacol; 2012 Aug; 262(3):321-9. PubMed ID: 22627062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.
    Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Takeda K; Utsunomiya H; Oda K; Warabi E; Ishii T; Osaka K; Hyodo I; Yamamoto M
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G735-47. PubMed ID: 18687751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
    Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
    Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.
    Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Sugimoto H; Utsunomiya H; Oda K; Warabi E; Ishii T; Yamamoto M
    Biochem Biophys Res Commun; 2009 Nov; 389(3):431-6. PubMed ID: 19732748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 protects against furosemide-induced hepatotoxicity.
    Qu Q; Liu J; Zhou HH; Klaassen CD
    Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keap1 inhibition attenuates glomerulosclerosis.
    Miyazaki Y; Shimizu A; Pastan I; Taguchi K; Naganuma E; Suzuki T; Hosoya T; Yokoo T; Saito A; Miyata T; Yamamoto M; Matsusaka T
    Nephrol Dial Transplant; 2014 Apr; 29(4):783-91. PubMed ID: 24523358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
    Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
    Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
    Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
    Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
    Reisman SA; Csanaky IL; Aleksunes LM; Klaassen CD
    Toxicol Sci; 2009 May; 109(1):31-40. PubMed ID: 19246624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet.
    Zhang YK; Wu KC; Liu J; Klaassen CD
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):305-14. PubMed ID: 23017736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis.
    Lu H; Cui W; Klaassen CD
    Toxicol Appl Pharmacol; 2011 Oct; 256(2):122-35. PubMed ID: 21846477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice.
    Zhang YK; Wu KC; Klaassen CD
    PLoS One; 2013; 8(3):e59122. PubMed ID: 23527105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet.
    Okada K; Warabi E; Sugimoto H; Horie M; Gotoh N; Tokushige K; Hashimoto E; Utsunomiya H; Takahashi H; Ishii T; Yamamoto M; Shoda J
    J Gastroenterol; 2013 May; 48(5):620-32. PubMed ID: 22972520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
    Zhang DD; Hannink M
    Mol Cell Biol; 2003 Nov; 23(22):8137-51. PubMed ID: 14585973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1.
    Cheng Q; Taguchi K; Aleksunes LM; Manautou JE; Cherrington NJ; Yamamoto M; Slitt AL
    J Biochem Mol Toxicol; 2011; 25(5):320-9. PubMed ID: 21538727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.